NFKB1 and COVID-19: FBA was also able to up-regulate the expression of genes involved in the TLR signaling pathway, such as CHUK, an inhibitor of Nf-kB [27], TRAF6, a mediator of the inflammatory response [28] and Irf7, which is correlated with COVID-19 gastrointestinal symptoms [29].